David Happel - Insider Trading & Ownership

Entity: Individual
Location: 7 Hamilton Landing, Suite 100, Novato, CA
Summary: The estimated net worth of David Happel is at least $5.76M dollars as of February 7, 2025. David Happel is the President & CEO, Director of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $5.76M.
All Insider Reports: All Insider Reports

Ownership of David Happel

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SGMT	Sagimet Biosciences Inc.	President & CEO, Director	$5.76M			Feb 6, 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.